Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom

British Journal of Cancer

Volumn 110, Issue 10, 2014, Pages 2412-2419

  Gunsoy, N B ^a   Garcia Closas, M ^a   Moss, S M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; SIMULATION; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMPUTER SIMULATION; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; MARKOV CHAINS; MIDDLE AGED; MODELS, THEORETICAL; SURVIVAL ANALYSIS; UNNECESSARY PROCEDURES;

EID: 84900530662     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.206     Document Type: Article

References (30)

1. Allgood PC, Duffy SW, Kearins O, O?Sullivan E, Tappenden N, Wallis MG, Lawrence G (2011) Explaining the difference in prognosis between screendetected and symptomatic breast cancers. Br J Cancer 104: 1680-1685.
2. Beral V, Alexander M, Duffy S, Ellis IO, Given-Wilson R, Holmberg L, Moss SM, Ramirez A, ReedMW , Rubin C, Whelehan P, Wilson R, Young KC (2011) The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. J Med Screen 18: 210-212.
3. Biesheuvel C Barratt A Howard K Houssami N Irwig L 2007 Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: A systematic review Lancet Oncol 8 1129-1138
4. Blamey RW, Ellis IO, Pinder SE, Lee AHS, Macmillan RD, Morgan DAL, Robertson JFR, Mitchell MJ, Ball GR, Haybittle JL, Elston CW (2007) Survival of invasive breast cancer according to the Nottingham Prognostic Index in cas es diagnosed in 1990-1999. Eur J Cancer 43: 1548-1555.
5. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ (2000) Effect of NHS breast screening programme on mortality from breast cancer in England an d Wales, 1990-8: Comparison of observed with predicted mortality. BMJ 321: 665-669.
6. Breast Screening Frequency Trial Group (2002) The frequency of breast cancer screening: Results from the UKCCCR randomised trial. United Kingdom Co-ordinating Committee on Cancer Research. Eur J Cancer 38: 1458-1464.
7. De Gelder R, Heijnsdijk EAM, Van Ravesteyn NT, Fracheboud J, Draisma G, De Koning HJ (2011) Interpreting overdiagno sis estimates in populationbased mammography screening. Epidemiol Rev 33: 111-121.
8. Duffy SW, Day NE, Tabar L, Chen H-H, Smith TC (1997) Markov models of breast tumor progression: Some age-specific results. J Natl Cancer Inst Monogr 22: 93-97.
9. Early Breast Cancer Trialists ?Collaborative GroupCorrea C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S (20 10) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010: 162-177.
10. Gunsoy NB, Garcia-Closas M, Moss SM (2012) Modelling the overdiagno sis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom. Breast Cancer Res 14: R152.
11. Lunn D, Spiegelhalter D, Thomas A, Best N (2009) The BUGS project: Evolution, critique and future directions. Stat Med 28: 3049-3067.
12. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M (2013) The benefits and harms of breast cancer screening: An independent rev iew. Br J Cancer 108: 2205-2240.
13. Moss S (1999) A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. J Med Screen 6: 144-148.
14. Moss SM, Coleman DA, Ellman R, Chamberlain J, Forrest AP, Kirkpatrick AE, Thomas BA, Price JL (1993) Interval cancers and sensitivity in the screening centres of the UK trial of early detec tion of breast cancer. Eur J Cancer 29A: 255-258.
15. NHS Breast Screening Programme( 2010) Age extension full randomised control trial http://www.clinicaltrials.gov/ct2/show/NCT01081288 (accessed 20 November 2013).
16. NHS Breast Screening Programme (2010) Age extension full randomised control trial. http://www.clinicaltrials.gov/ct2/show/NCT01081288 (accessed 20 November 2013).
17. NHS Breast Screening Programme (2012) Statistics bulletin: Breast screening programme, England. http://www.cancerscreening.nhs.uk/(accessed 20 November 2013
18. Office for National Statistics (2008) Mortality statistics: Deaths registrations (Series DR). http://www.ons.gov.uk/(accessed 20 November 2013
19. Paci E. EUROSCREEN Working Gro up (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 19(Suppl 1): 5-13.
20. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD (2002) Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat Res 158: 220-235.
21. Puliti D, Miccinesi G, Paci E (2011) Overdiagnosis in breast cancer: Design and methods of estimation in observational studies. Prev Med 53: 131-133.
22. Taylor R, Davis P, Boyages J (2003) Long-term survival of women with breast cancer in New South Wales. Eur J Cancer 39: 215-222.
23. Van Ravesteyn NT, Heijnsdijk EAM, Draisma G, De Koning HJ (2011) Prediction of higher mortality reduction for the UK breast screening frequency trial: A model-based approach on s creening intervals. Br J Cancer 105: 1082-1088.
24. Wai ES, D?Yachkova Y, Olivotto IA, Tyldesley S, Phillips N, Warren LJ, Coldman AJ (2005) Comparison of 1-and 2-year screening intervals for wo men undergoing screening mammography. Br J Cancer 92: 961-966.
25. West Midlands Cancer Intelligence Unit (2007) Breast Cancer Clinical Outcome Measures (BCCOM) Project; analysis of the management of symptomatic breast cancers diagnosed in 2004; 3rd year report http://www. associationofbreastsurgery.org.uk/media/2327/bccom-ar09.pdf (accessed 20 November 2013). (accessed 20 November 2013).
26. Wishart GC, Greenberg DC, Britton PD, Chou P, Brown CH, Purushotham AD, Duf fy SW(2008) Screen-detected vs symptomatic breast cancer: Is improved survival due to stage migration alone Br J Cancer 98: 1741-1744.
27. Wishart GC, Azzato EM, Greenberg DC, Rashbass J, Kearins O, Lawrence G, Caldas C, Pharoah PD (2010) PREDICT: A new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 12: R1.
28. Yen M-F, Tabá r L, Vitak B, Smith RA, Chen H-H, Duffy SW (2003) Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 39: 1746-1754.
29. Young KC (2002) Radiatio n doses in the UK trial of breast screening in women aged 40-48 years. Br J Radiol 75: 362-370.
30. Young KC, Burch A, Oduko JM (2005) Radiation doses received in the UK breast screening programme in 2001 and 2002. Br J Radiol 78: 207-218.